{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:47:15Z","timestamp":1790282835664,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"NWO-ZonMW","award":["435002027"],"award-info":[{"award-number":["435002027"]}]},{"DOI":"10.13039\/501100015066","name":"Virgo Consortium","doi-asserted-by":"crossref","award":["FES0908"],"award-info":[{"award-number":["FES0908"]}],"id":[{"id":"10.13039\/501100015066","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13073-016-0318-8","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T13:54:32Z","timestamp":1465566872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Metabolic characterization of the natural progression of chronic hepatitis B"],"prefix":"10.1186","volume":"8","author":[{"given":"Johannes C.","family":"Schoeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"Vreeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hankemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Boonstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"issue":"1 Suppl","key":"318_CR1","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","volume":"62","author":"S Locarnini","year":"2015","unstructured":"Locarnini S, Hatzakis A, Chen D-S, Lok A. Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. J Hepatol. 2015;62(1 Suppl):S76\u201386.","journal-title":"J Hepatol"},{"issue":"2","key":"318_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48(2):335\u201352.","journal-title":"J Hepatol"},{"issue":"5","key":"318_CR3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","volume":"8","author":"H Kwon","year":"2011","unstructured":"Kwon H, Lok AS. Hepatitis B therapy. Nat Rev Gastroenterol Hepatol. 2011;8(5):275\u201384.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"318_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/pathogens3020377","volume":"3","author":"T Inuzuka","year":"2014","unstructured":"Inuzuka T, Takahashi K, Chiba T, Marusawa H. Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions. Pathogens. 2014;3(2):377\u201389.","journal-title":"Pathogens"},{"issue":"5","key":"318_CR5","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ajpath.2015.01.028","volume":"185","author":"Y Ishida","year":"2015","unstructured":"Ishida Y, Yamasaki C, Yanagi A, Yoshizane Y, Fujikawa K, Watashi K, et al. Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. Am J Pathol. 2015;185(5):1275\u201385.","journal-title":"Am J Pathol"},{"issue":"6","key":"318_CR6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jbiosc.2012.12.007","volume":"115","author":"SP Putri","year":"2013","unstructured":"Putri SP, Nakayama Y, Matsuda F, Uchikata T, Kobayashi S, Matsubara A, et al. Current metabolomics: practical applications. J Biosci Bioeng. 2013;115(6):579\u201389.","journal-title":"J Biosci Bioeng"},{"issue":"2","key":"318_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/bib\/bbl012","volume":"7","author":"V Shulaev","year":"2006","unstructured":"Shulaev V. Metabolomics technology and bioinformatics. Brief Bioinform. 2006;7(2):128\u201339.","journal-title":"Brief Bioinform"},{"issue":"3","key":"318_CR8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.mib.2004.04.012","volume":"7","author":"DB Kell","year":"2004","unstructured":"Kell DB. Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol. 2004;7(3):296\u2013307.","journal-title":"Curr Opin Microbiol"},{"key":"318_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","volume":"32","author":"JF Xiao","year":"2012","unstructured":"Xiao JF, Zhou B, Ressom HW. Metabolite identification and quantitation in LC\u2013MS\/MS-based metabolomics. Trends Anal Chem. 2012;32:1\u201314.","journal-title":"Trends Anal Chem."},{"issue":"5","key":"318_CR10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cbpa.2013.06.015","volume":"17","author":"R Ramautar","year":"2013","unstructured":"Ramautar R, Berger R, van der Greef J, Hankemeier T. Human metabolomics: strategies to understand biology. Curr Opin Chem Biol. 2013;17(5):841\u20136.","journal-title":"Curr Opin Chem Biol"},{"issue":"8","key":"318_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4155\/bio.12.61","volume":"4","author":"T Pacchiarotta","year":"2012","unstructured":"Pacchiarotta T, Deelder AM, Mayboroda OA. Metabolomic investigations of human infections. Bioanalysis. 2012;4(8):919\u201325.","journal-title":"Bioanalysis"},{"issue":"1","key":"318_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/cb900271r","volume":"5","author":"N Vinayavekhin","year":"2010","unstructured":"Vinayavekhin N, Homan EA, Saghatelian A. Exploring disease through metabolomics. ACS Chem Biol. 2010;5(1):91\u2013103.","journal-title":"ACS Chem Biol"},{"issue":"12","key":"318_CR13","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.ppat.0020132","volume":"2","author":"J Munger","year":"2006","unstructured":"Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD. Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog. 2006;2(12):e132.","journal-title":"PLoS Pathog"},{"issue":"7","key":"318_CR14","doi-asserted-by":"crossref","first-page":"e1002124","DOI":"10.1371\/journal.ppat.1002124","volume":"7","author":"L Vastag","year":"2011","unstructured":"Vastag L, Koyuncu E, Grady SL, Shenk TE, Rabinowitz JD. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism. PLoS Pathog. 2011;7(7):e1002124.","journal-title":"PLoS Pathog"},{"issue":"19","key":"318_CR15","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1002\/elps.201200629","volume":"34","author":"S Chen","year":"2013","unstructured":"Chen S, Yin P, Zhao X, Xing W, Hu C, Zhou L, et al. Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC\/IT-TOF MS. Electrophoresis. 2013;34(19):2848\u201356.","journal-title":"Electrophoresis"},{"key":"318_CR16","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1038\/srep08421","volume":"5","author":"H Li","year":"2015","unstructured":"Li H, Zhu W, Zhang L, Lei H, Wu X, Guo L, et al. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment. Sci Rep. 2015;5:8421.","journal-title":"Sci Rep."},{"issue":"1","key":"318_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mc.22266","volume":"55","author":"C-F Teng","year":"2016","unstructured":"Teng C-F, Hsieh W-C, Yang C-W, Su H-M, Tsai T-F, Sung W-C, et al. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis. Mol Carcinog. 2016;55(1):105\u201314.","journal-title":"Mol Carcinog"},{"issue":"3","key":"318_CR18","first-page":"1","volume":"32","author":"J Kwarteng","year":"2012","unstructured":"Kwarteng J, Owusu L, Afihene M. Lowered serum triglyceride levels among chronic hepatitis B-infected patients in Ghana. J Sci Technol. 2012;32(3):1\u201310.","journal-title":"J Sci Technol"},{"key":"318_CR19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2015.01.020","volume":"33","author":"S-J Zheng","year":"2015","unstructured":"Zheng S-J, Qu F, Li J-F, Zhao J, Zhang J-LJ-Y, Liu M, et al. Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection. Int J Infect Dis. 2015;33:149\u201355.","journal-title":"Int J Infect Dis."},{"issue":"1","key":"318_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00216-012-5782-4","volume":"403","author":"L Zhou","year":"2012","unstructured":"Zhou L, Wang Q, Yin P, Xing W, Wu Z, Chen S, et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem. 2012;403(1):203\u201313.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"318_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/annotation\/f089122e-03d9-4715-9d92-c284f8d8b416","volume":"8","author":"A Zhang","year":"2013","unstructured":"Zhang A, Sun H, Han Y, Yan G, Wang X. Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC\u2013MS system. PLoS One. 2013;8(5):1\u20138.","journal-title":"PLoS One"},{"key":"318_CR22","first-page":"1","volume":"2013","author":"S Sun","year":"2013","unstructured":"Sun S, Dai J, Fang J, Gou X, Cao H, Zheng N, et al. Differences of excess and deficiency in patients with chronic hepatitis B by urinary metabonomics. Evid Based Complement Altern Med. 2013;2013:1\u201310.","journal-title":"Evid Based Complement Altern Med."},{"issue":"4","key":"318_CR23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2011.01.031","volume":"55","author":"T Soga","year":"2011","unstructured":"Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, et al. Serum metabolomics reveals \u03b3-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. J Hepatol. 2011;55(4):896\u2013905.","journal-title":"J Hepatol"},{"issue":"3","key":"318_CR24","first-page":"305","volume":"47","author":"R Xue","year":"2009","unstructured":"Xue R, Dong L, Wu H, Liu T, Wang J, Shen X. Gas chromatography\/mass spectrometry screening of serum metabolomic biomarkers in hepatitis B virus infected cirrhosis patients. Clin Chem Lab Med. 2009;47(3):305\u201310.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"318_CR25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","volume":"58","author":"D Beyo\u01e7lu","year":"2013","unstructured":"Beyo\u01e7lu D, Imbeaud S, Maurhofer O, Bioulac-Sage P, Zucman-Rossi J, Dufour JF, et al. Tissue metabolomics of hepatocellular carcinoma: Tumor energy metabolism and the role of transcriptomic classification. Hepatology. 2013;58(1):229\u201338.","journal-title":"Hepatology"},{"issue":"8","key":"318_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1039\/b820224a","volume":"5","author":"P Yin","year":"2009","unstructured":"Yin P, Wan D, Zhao C, Chen J, Zhao X, Wang W, et al. A metabonomic study of hepatitis B-induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol Biosyst. 2009;5(8):868\u201376.","journal-title":"Mol Biosyst"},{"issue":"1","key":"318_CR27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"E Association","year":"2012","unstructured":"Association E. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167\u201385.","journal-title":"J Hepatol"},{"issue":"W1","key":"318_CR28","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"318_CR29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6(6):743\u201360.","journal-title":"Nat Protoc"},{"key":"318_CR30","first-page":"1027","volume":"8","author":"D Arthur","year":"2007","unstructured":"Arthur D, Vassilvitskii S. k-means++: The advantages of careful seeding. Proc Eighteenth Annu ACM-SIAM Symp Discret Algorithms. 2007;8:1027\u201335.","journal-title":"Proc Eighteenth Annu ACM-SIAM Symp Discret Algorithms"},{"issue":"4","key":"318_CR31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.rmed.2010.12.002","volume":"105","author":"PV Dicpinigaitis","year":"2011","unstructured":"Dicpinigaitis PV, Bhat R, Rhoton WA, Tibb AS, Negassa A. Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med. 2011;105(4):615\u20138.","journal-title":"Respir Med"},{"issue":"5","key":"318_CR32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/gut.23.5.362","volume":"23","author":"MY Morgan","year":"1982","unstructured":"Morgan MY, Marshall AW, Milsom JP, Sherlock S. Plasma amino-acid patterns in liver disease. Gut. 1982;23(5):362\u201370.","journal-title":"Gut"},{"issue":"suppl","key":"318_CR33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ajcn\/76.5.1183S","volume":"76","author":"CS Lieber","year":"2002","unstructured":"Lieber CS. S-Adenosyl-L-methionine: its role in the treatment of liver disorders. Am J Clin Nutr. 2002;76(suppl):1183\u20137S.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"318_CR34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2811","volume":"18","author":"S Zeissig","year":"2012","unstructured":"Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, et al. Hepatitis B virus\u2013induced lipid alterations contribute to natural killer T cell\u2013dependent protective immunity. Nat Med. 2012;18(7):1060\u20138.","journal-title":"Nat Med"},{"issue":"10","key":"318_CR35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1440-1746.2004.03435.x","volume":"19","author":"M Ito","year":"2004","unstructured":"Ito M, Ishikawa Y, Kiguchi H, Komiyama K, Murakami M, Kudo I, et al. Distribution of type V secretory phospholipase A2 expression in human hepatocytes damaged by liver disease. J Gastroenterol Hepatol. 2004;19(10):1140\u20139.","journal-title":"J Gastroenterol Hepatol"},{"issue":"19","key":"318_CR36","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMra1104901","volume":"365","author":"O Quehenberger","year":"2011","unstructured":"Quehenberger O, Dennis EA. The human plasma lipidome. N Engl J Med. 2011;365(19):1812\u201323.","journal-title":"N Engl J Med"},{"issue":"7","key":"318_CR37","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0022-2275(20)42638-0","volume":"31","author":"O Satoh","year":"1990","unstructured":"Satoh O, Umeda M, Imai H, Tunoo H, Inoue K. Lipid composition of hepatitis B virus surface antigen particles and the particle-producing human hepatoma cell lines. J Lipid Res. 1990;31(7):1293\u2013300.","journal-title":"J Lipid Res"},{"key":"318_CR38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","volume":"2","author":"KD Corbin","year":"2012","unstructured":"Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012;2:159\u201365.","journal-title":"Curr Opin Gastroenterol."},{"key":"318_CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.nu.14.070194.001413","volume":"14","author":"SH Zeisel","year":"1994","unstructured":"Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr. 1994;14:269\u201396.","journal-title":"Annu Rev Nutr."},{"issue":"10","key":"318_CR40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/carcin\/5.10.1367","volume":"5","author":"AK Ghoshal","year":"1984","unstructured":"Ghoshal AK, Farber E. The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis. 1984;5(10):1367\u201370.","journal-title":"Carcinogenesis"},{"issue":"3","key":"318_CR41","first-page":"309","volume":"113","author":"AK Ghoshal","year":"1983","unstructured":"Ghoshal AK, Ahluwalia M, Farber E. The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet. Am J Pathol. 1983;113(3):309\u201314.","journal-title":"Am J Pathol"},{"issue":"1","key":"318_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2680001","volume":"286","author":"GF Gibbons","year":"1990","unstructured":"Gibbons GF. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J. 1990;286(1):1\u201313.","journal-title":"Biochem J"},{"issue":"6","key":"318_CR43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10408369891234246","volume":"35","author":"TM Mason","year":"1998","unstructured":"Mason TM. The role of factors that regulate the synthesis and secretion of very-low-density lipoprotein by hepatocytes. Crit Rev Clin Lab Sci. 1998;35(6):461\u201387.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"7 Pt 1","key":"318_CR44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1440-1746.2008.05478.x","volume":"23","author":"D Peng","year":"2008","unstructured":"Peng D, Han Y, Ding H, Wei L. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1082\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"318_CR45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1440-1746.2011.06801.x","volume":"26","author":"MV Machado","year":"2011","unstructured":"Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26(9):1361\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"318_CR46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","volume":"49","author":"M Adiels","year":"2006","unstructured":"Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49(4):755\u201365.","journal-title":"Diabetologia"},{"issue":"8","key":"318_CR47","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844\u201350.","journal-title":"Diabetes"},{"issue":"13","key":"318_CR48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01477666","volume":"57","author":"KP Maier","year":"1979","unstructured":"Maier KP, Talke H, Gerok W. Activities of urea-cycle enzymes in chronic liver disease. Klin Wochenschr. 1979;57(13):661\u20135.","journal-title":"Klin Wochenschr"},{"issue":"7506","key":"318_CR49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju AK, Erion DM, Rahimi Y, Zhang X-M, Braddock DT, Albright RA, et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. 2014;510(7506):542\u20136.","journal-title":"Nature"},{"issue":"8","key":"318_CR50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/jvh.12187","volume":"21","author":"Y-H Xun","year":"2014","unstructured":"Xun Y-H, Zhang Y-J, Pan Q-C, Mao R-C, Qin Y-L, Liu H-Y, et al. Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells. J Viral Hepat. 2014;21(8):597\u2013603.","journal-title":"J Viral Hepat"},{"issue":"2","key":"318_CR51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11306-011-0306-3","volume":"8","author":"MJ Noga","year":"2012","unstructured":"Noga MJ, Dane A, Shi S, Attali A, van Aken H, Suidgeest E, et al. Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis. Metabolomics. 2012;8(2):253\u201363.","journal-title":"Metabolomics"},{"issue":"11","key":"318_CR52","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1021\/pr800373m","volume":"7","author":"C Hu","year":"2008","unstructured":"Hu C, van Dommelen J, van der Heijden R, Spijksma G, Reijmers TH, Wang M, et al. RPLC-ion-trap-FTMS method for lipid profiling of plasma: method validation and application to p53 mutant mouse model. J Proteome Res. 2008;7(11):4982\u201391.","journal-title":"J Proteome Res"},{"issue":"5","key":"318_CR53","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00216-012-6226-x","volume":"404","author":"K Strassburg","year":"2012","unstructured":"Strassburg K, Huijbrechts AML, Kortekaas KA, Lindeman JH, Pedersen TL, Dane A, et al. Quantitative profiling of oxylipins through comprehensive LC\u2013MS\/MS analysis: application in cardiac surgery. Anal Bioanal Chem. 2012;404(5):1413\u201326.","journal-title":"Anal Bioanal Chem"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-016-0318-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T14:07:42Z","timestamp":1718633262000},"score":1,"resource":{"primary":{"URL":"http:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-016-0318-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1186\/s13073-016-0318-8","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"article-number":"64"}}